Diagnosis and treatment of breast cancer in young women
L Rossi, C Mazzara, O Pagani - Current treatment options in oncology, 2019 - Springer
Opinion statement Despite the increase of breast cancer incidence with age, approximately
7 to 10% ofwomen diagnosed with breast cancer are younger than the age 40. This …
7 to 10% ofwomen diagnosed with breast cancer are younger than the age 40. This …
Psychological impact of alterations in sexuality, fertility, and body image in young breast cancer patients and their partners
M Miaja, A Platas… - Revista de investigacion …, 2017 - medigraphic.com
Young women with breast cancer have age-specific concerns regarding changes in
sexuality, fertility, and body image. However, the psychological impact of BC and its …
sexuality, fertility, and body image. However, the psychological impact of BC and its …
Fertility preservation in patients with cancer: ASCO clinical practice guideline update
Purpose To provide current recommendations about fertility preservation for adults and
children with cancer. Methods A systematic review of the literature published from January …
children with cancer. Methods A systematic review of the literature published from January …
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Background In MONALEESA-2, ribociclib plus letrozole showed improved progression-free
survival compared with letrozole alone as first-line treatment for postmenopausal patients …
survival compared with letrozole alone as first-line treatment for postmenopausal patients …
[HTML][HTML] ESO–ESMO 4th international consensus guidelines for breast cancer in young women (BCY4)
Highlights•Breast cancer in young women should be treated based on stage and biology of
disease.•Management of breast cancer in young women requires special considerations …
disease.•Management of breast cancer in young women requires special considerations …
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)
S Paluch-Shimon, O Pagani, AH Partridge, O Abulkhair… - The Breast, 2017 - Elsevier
Abstract The 3rd International Consensus Conference for Breast Cancer in Young Women
(BCY3) took place in November 2016, in Lugano, Switzerland organized by the European …
(BCY3) took place in November 2016, in Lugano, Switzerland organized by the European …
[HTML][HTML] ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)
Highlights•Breast cancer in young women encompasses unique treatment and survivorship
considerations.•Fertility, ovarian function suppression and premature menopause are major …
considerations.•Fertility, ovarian function suppression and premature menopause are major …
Adding ovarian suppression to tamoxifen for premenopausal breast cancer: a randomized phase III trial
PURPOSE The addition of ovarian function suppression (OFS) for 5 years to tamoxifen
(TAM) for treatment of premenopausal patients with breast cancer after completion of …
(TAM) for treatment of premenopausal patients with breast cancer after completion of …
Fertility preservation using GnRH agonists: rationale, possible mechanisms, and explanation of controversy
Z Blumenfeld - Clinical Medicine Insights: Reproductive …, 2019 - journals.sagepub.com
The only clinically accepted method of fertility preservation in young women facing
gonadotoxic chemo-and/or radiotherapy for malignant or autoimmune diseases is …
gonadotoxic chemo-and/or radiotherapy for malignant or autoimmune diseases is …
[HTML][HTML] Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: a GRADE approach for evidence …
M Lambertini, M Cinquini, I Moschetti… - European Journal of …, 2017 - Elsevier
The development of premature ovarian failure and subsequent infertility are possible
consequences of chemotherapy use in pre-menopausal women with early-stage breast …
consequences of chemotherapy use in pre-menopausal women with early-stage breast …